These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32585080)

  • 121. FGF-21 as a Potential Biomarker for Mitochondrial Diseases.
    Scholle LM; Lehmann D; Deschauer M; Kraya T; Zierz S
    Curr Med Chem; 2018; 25(18):2070-2081. PubMed ID: 29332568
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice.
    Morovat A; Weerasinghe G; Nesbitt V; Hofer M; Agnew T; Quaghebeur G; Sergeant K; Fratter C; Guha N; Mirzazadeh M; Poulton J
    J Clin Med; 2017 Aug; 6(8):. PubMed ID: 28825656
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Recent Advances in Mitochondrial Disease.
    Craven L; Alston CL; Taylor RW; Turnbull DM
    Annu Rev Genomics Hum Genet; 2017 Aug; 18():257-275. PubMed ID: 28415858
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis.
    Chung HK; Ryu D; Kim KS; Chang JY; Kim YK; Yi HS; Kang SG; Choi MJ; Lee SE; Jung SB; Ryu MJ; Kim SJ; Kweon GR; Kim H; Hwang JH; Lee CH; Lee SJ; Wall CE; Downes M; Evans RM; Auwerx J; Shong M
    J Cell Biol; 2017 Jan; 216(1):149-165. PubMed ID: 27986797
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Growth Differentiation Factor 15 Is a Novel Diagnostic Biomarker of Mitochondrial Diseases.
    Ji X; Zhao L; Ji K; Zhao Y; Li W; Zhang R; Hou Y; Lu J; Yan C
    Mol Neurobiol; 2017 Dec; 54(10):8110-8116. PubMed ID: 27889897
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Elevated FGF 21 in myotonic dystrophy type 1 and mitochondrial diseases.
    Lovadi E; Csereklyei M; Merkli H; FüLöp K; Sebők Á; Karcagi V; Komoly S; Pál E
    Muscle Nerve; 2017 Apr; 55(4):564-569. PubMed ID: 27489983
    [TBL] [Abstract][Full Text] [Related]  

  • 127. A comparison of current serum biomarkers as diagnostic indicators of mitochondrial diseases.
    Davis RL; Liang C; Sue CM
    Neurology; 2016 May; 86(21):2010-5. PubMed ID: 27164684
    [TBL] [Abstract][Full Text] [Related]  

  • 128. GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction.
    Montero R; Yubero D; Villarroya J; Henares D; Jou C; Rodríguez MA; Ramos F; Nascimento A; Ortez CI; Campistol J; Perez-Dueñas B; O'Callaghan M; Pineda M; Garcia-Cazorla A; Oferil JC; Montoya J; Ruiz-Pesini E; Emperador S; Meznaric M; Campderros L; Kalko SG; Villarroya F; Artuch R; Jimenez-Mallebrera C
    PLoS One; 2016; 11(2):e0148709. PubMed ID: 26867126
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Understanding the Physiology of FGF21.
    Fisher FM; Maratos-Flier E
    Annu Rev Physiol; 2016; 78():223-41. PubMed ID: 26654352
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Mitochondrial disease in adults: what's old and what's new?
    Chinnery PF
    EMBO Mol Med; 2015 Dec; 7(12):1503-12. PubMed ID: 26612854
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders.
    Yatsuga S; Fujita Y; Ishii A; Fukumoto Y; Arahata H; Kakuma T; Kojima T; Ito M; Tanaka M; Saiki R; Koga Y
    Ann Neurol; 2015 Nov; 78(5):814-23. PubMed ID: 26463265
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Serum GDF15 Levels Correlate to Mitochondrial Disease Severity and Myocardial Strain, but Not to Disease Progression in Adult m.3243A>G Carriers.
    Koene S; de Laat P; van Tienoven DH; Weijers G; Vriens D; Sweep FC; Timmermans J; Kapusta L; Janssen MC; Smeitink JA
    JIMD Rep; 2015; 24():69-81. PubMed ID: 25967227
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease.
    Gorman GS; Schaefer AM; Ng Y; Gomez N; Blakely EL; Alston CL; Feeney C; Horvath R; Yu-Wai-Man P; Chinnery PF; Taylor RW; Turnbull DM; McFarland R
    Ann Neurol; 2015 May; 77(5):753-9. PubMed ID: 25652200
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.
    Parikh S; Goldstein A; Koenig MK; Scaglia F; Enns GM; Saneto R; Anselm I; Cohen BH; Falk MJ; Greene C; Gropman AL; Haas R; Hirano M; Morgan P; Sims K; Tarnopolsky M; Van Hove JL; Wolfe L; DiMauro S
    Genet Med; 2015 Sep; 17(9):689-701. PubMed ID: 25503498
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Role of plasma amino acids and urinary organic acids in diagnosis of mitochondrial diseases in children.
    Shatla HM; Tomoum HY; Elsayed SM; Elagouza IA; Shatla RH; Mohsen MM; Hamed AN
    Pediatr Neurol; 2014 Dec; 51(6):820-5. PubMed ID: 25456303
    [TBL] [Abstract][Full Text] [Related]  

  • 136. GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases.
    Fujita Y; Ito M; Kojima T; Yatsuga S; Koga Y; Tanaka M
    Mitochondrion; 2015 Jan; 20():34-42. PubMed ID: 25446397
    [TBL] [Abstract][Full Text] [Related]  

  • 137. An overview of systematic reviews of diagnostic tests accuracy.
    Bae JM
    Epidemiol Health; 2014; 36():e2014016. PubMed ID: 25209601
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Serum FGF21 levels in adult m.3243A>G carriers: clinical implications.
    Koene S; de Laat P; van Tienoven DH; Vriens D; Brandt AM; Sweep FC; Rodenburg RJ; Donders AR; Janssen MC; Smeitink JA
    Neurology; 2014 Jul; 83(2):125-33. PubMed ID: 24907231
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies.
    Kalko SG; Paco S; Jou C; Rodríguez MA; Meznaric M; Rogac M; Jekovec-Vrhovsek M; Sciacco M; Moggio M; Fagiolari G; De Paepe B; De Meirleir L; Ferrer I; Roig-Quilis M; Munell F; Montoya J; López-Gallardo E; Ruiz-Pesini E; Artuch R; Montero R; Torner F; Nascimento A; Ortez C; Colomer J; Jimenez-Mallebrera C
    BMC Genomics; 2014 Feb; 15():91. PubMed ID: 24484525
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Fibroblast growth factor 21, a biomarker for mitochondrial muscle disease.
    Gavrilova R; Horvath R
    Neurology; 2013 Nov; 81(21):1808-9. PubMed ID: 24142478
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.